I’m CEO of San Diego Biotechnology Connection (https://sandiegobiotechnology.com). I have a M.S. degree (microbiology) from the University of Iowa and completed a one-year science journalism fellowship at MIT. I have been an award-winning science writer and editor for 30 years for newspapers, magazines and research institutes and I have won numerous awards from state medical societies, state Associated Press Managing Editors associations, the American College of Emergency Physicians and a Silver Gavel Award from the American Bar Association. I was senior director of communications for UC San Diego prior to founding San Diego Biotechnology Connection.
Currently Vice President of Business Development dedicated to the discovery and creation of shareholder value for Life Science companies.
--Extensive Scientific Research experience in Pharmaceutical and Medical Device Companies AMGEN, ALLERGAN
--Experience as Technical Liaison/Advisor for prominent financial institutions focused on Healthcare and Biotech investments
Prior experience includes:
AMGEN: (Research Scientist ) Drug Product Process Development, Drug Engineering, FDA technology- liaison, Product Characterization, Commercial Manufacturing Support, Commercial Drug Development , Drug Formulation and Pre-commercial Drug Product Tech Transfer.
ALLERGAN: (Research Scientist) Project design and management of proprietary materials and data for medical device and medical aesthetic products. Scientific research team lead of collagen and capsular-contracture studies for devices. Biomaterial optimization applying advanced histology, cell culture and immunohistochemistry.
OPUS Point Partners/OPN Capital Markets/ National Securities: Scientific Advisor and technology liaison. Worked alongside lead market strategist and lead biotech analyst at National Securities for The Biotech Group. Lead the due diligence process for the Managing Director at OPN Capital Markets, reviewing product mechanisms,intellectual property and overall technology/concept viability.
Retail Investor, Shareholder Advocate and Editor of Stocks DD blog. You are cautioned to read the disclaimer in Seeking Alpha before reading my articles. I am NOT a registered investment adviser. My articles are ONLY for informative purposes and should NOT be treated as investment advice.
My investment philosophy:
1. Invest in Strong businesses (high barriers to entry) 2. Invest in Management with excellent track record for shareholder value creation 3. Invest at undervalued prices
Invest in special situations (bankruptcy or other restructuring) or Drug development firms, where there is with an asymmetric reward/risk...where I have strong conviction on a reward event.
I am also interested in the shareholders topics in publicly listed companies:
1. Shareholder rights 2. Giving shareholders a voice incl shareholder participation in value creation 3. Improving board and management's accountability to shareholders
Be a shareholder advocate and work towards insuring boards and management "do the right thing for shareholders", maximizing and protecting shareholder's value.
More on my ideas can be found here:
I'm a rookie, fifty year old investor. Right now I moved my old 401-K into a I.R.A. at Scottrade. I got some lucky calls with LNG, Apple, and EEM so doing pretty good. 20% gain in only five months. :)